Nkarta, Inc. - Common Stock (NQ:NKTX)

2.100 -0.070 (-3.23%)

Delayed Quote Updated: 4:00 PM EDT, Oct 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Nkarta Targets ACR 2026 Data Reveal as Outpatient CAR NK Trials Advance ↗

September 27, 2026

Nkarta (NASDAQ:NKTX) said it expects to present initial clinical data from its autoimmune disease programs at the American College of Rheumatology’s 2026 Convergence meeting in November, including...

Via MarketBeat

Nkarta (NASDAQ:NKTX) Q1 2026 Narrower Loss Beats Estimates as Autoimmune Trial Advances ↗

May 12, 2026

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 28, 2025

Via Benzinga

Nkarta Posts Narrower Loss in Q2 ↗

August 13, 2025

Via The Motley Fool

Topics Intellectual Property

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space ↗

May 15, 2025

Nkarta posts a smaller Q1 loss than expected and maintains strong cash reserves while analysts debate its trial strategy and market position.

Via Benzinga

NKTX Stock Earnings: Nkarta Beats EPS for Q2 2024 ↗

August 13, 2024

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

NKTX Stock Earnings: Nkarta Beats EPS for Q1 2024 ↗

May 09, 2024

NKTX stock results show that Nkarta beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

May 15, 2025

Via Benzinga

Top movers in Thursday's session ↗

March 27, 2025

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Top stock movements in today's session. ↗

March 27, 2025

Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 27, 2025

Via Benzinga

Why Is Autoimmune Disease Focused Nkarta Stock Trading Higher On Thursday? ↗

March 27, 2025

Nkarta restructures to extend its cash runway into 2029, with upcoming NKX019 clinical data readouts in H2 2025. Analysts maintain Buy ratings.

Via Benzinga

Which stocks are gapping on Thursday? ↗

March 27, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗

October 08, 2024

Via Benzinga

Why Nkarta Stock Is Soaring Today ↗

August 14, 2024

One analyst is now more bullish about this clinical-stage biotech stock.

Via The Motley Fool

UBS Posts Upbeat Earnings, Joins Victoria's Secret, Performance Food Group, Kellanova And Other Big Stocks Moving Higher On Wednesday ↗

August 14, 2024

Via Benzinga

Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

August 14, 2024

Via Benzinga

3 Undervalued Stocks Primed for a 2X Return ↗

July 01, 2024

Discover compelling investment opportunities with top undervalued stocks for high returns leading in healthcare and software.

Via InvestorPlace

Opportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street’s Radar ↗

May 07, 2024

Explore these undiscovered stock picks attached with rapid growth in biotechnology, oil and gas, and pharmaceuticals.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 12, 2024

Via Benzinga

Small-Cap Firm Century Therapeutics' Expands into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing ↗

April 11, 2024

Century Therapeutics unveils plans to expand CNTY-101 clinical development into additional autoimmune diseases, including systemic lupus erythematosus. $60 million private placement supports R&D...

Via Benzinga

Nasdaq Turns Higher; Akanda Shares Plunge ↗

March 25, 2024

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 while the NASDAQ rose 0.06% to 16,439.38. The S&P 500 also...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 25, 2024

Via Benzinga

Crude Oil Moves Higher; US New Home Sales Fall In February ↗

March 25, 2024

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The...

Via Benzinga

Topics Stocks

Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 25, 2024

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

March 25, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 25, 2024

We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.

Via InvestorPlace

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 22, 2024

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Via Benzinga

Stocks Level Off, S&P 500 Nears Best Week Of 2024, NVIDIA Rallies For 11th Week, Bitcoin Sinks: What's Driving Markets Friday? ↗

March 22, 2024

Stocks slightly retreated during New York’s morning session on Friday, following another robust week of gains fueled by a dovish Federal Reserve meeting, which underscored Chair Jerome Powell‘s...

Via Benzinga

Topics Economy Stocks

Why Is Cancer Drug-Developer Nkarta Stock Trading Lower On Friday? ↗

March 22, 2024

Nkarta closed patient enrollment in NKX101 clinical trial, reallocating focus to lead program NKX019 for autoimmune disease. Recent expansion into autoimmune disease with FDA clearance for NKX019 in...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.